Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Impact of Intermittent Fasting in Combination With Checkpoint Inhibitors in Patients With Non-small Cell Lung Cancer

NCT06671613 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT06671613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06671613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Impact of Intermittent Fasting in Combination With Checkpoint Inhibitors in Patients With Non-small Cell Lung Cancer
Lead sponsor
VA Office of Research and Development
Phase
Not applicable
Overall status
Recruiting
Start date
October 27, 2025
Completion date
December 31, 2030
Enrollment
66 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

fasting mimicking diet, immunotherapy, nsclc, stage iv nsclc